Janet Woodcock already has a 30-year career at FDA. Most recently, she led the CDER (US FDA Center for Drug Evaluation and Research). Since May 2020, she has also been responsible for leading Operation Warp Speed to support the development of COVID-19 therapeutics. Woodcock will continue to perform this function.
As she says, she welcomes the challenge of leading FDA on a transitional basis because:
"The FDA’s public health work is more critical than ever as we continue to fight this global pandemic."
FDA: Janet Woodcock
Twitter: Janet Woodcock
> Do not hesitate, we look forward to your feedback!
Write a comment on this news.